data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Zynerba Pharmaceuticals
(NASDAQ:ZYNE)
$0.596
0.036[6.43%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$0.60
0.0040[0.67%]
After Hours: 7:49PM EDT
Day Range0.55 - 0.652 Wk Range0.5 - 3.61Open / Close0.56 / 0.6Float / Outstanding45.1M / 47.1M
Vol / Avg.211.8K / 316.4KMkt Cap28MP/E-50d Avg. Price0.69
Div / Yield-Payout Ratio-Total Float45.1MEPS-0.2

Zynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Quotes and News Summary

Zynerba Pharmaceuticals Stock (NASDAQ: ZYNE) stock price, news, charts, stock research, profile.

Day Range0.55 - 0.652 Wk Range0.5 - 3.61Open / Close0.56 / 0.6Float / Outstanding45.1M / 47.1M
Vol / Avg.211.8K / 316.4KMkt Cap28MP/E-50d Avg. Price0.69
Div / Yield-Payout Ratio-Total Float45.1MEPS-0.2
Vuk Zdinjak - Nov 14, 2022, 10:33AM
Vuk Zdinjak - Aug 10, 2022, 8:15AM
Vuk Zdinjak - Jul 21, 2022, 7:33AM
Vuk Zdinjak - Jun 22, 2022, 11:02AM
Vandana Singh - Jun 22, 2022, 10:39AM
Globe Newswire - 4 days ago
Globe Newswire - 5 days ago
Globe Newswire - Nov 15, 2022, 7:30AM
Globe Newswire - Nov 14, 2022, 7:30AM
Globe Newswire - Nov 2, 2022, 7:30AM
Globe Newswire - Oct 17, 2022, 7:00AM
Globe Newswire - Oct 10, 2022, 7:00AM
Globe Newswire - Oct 6, 2022, 7:00AM
Globe Newswire - Sep 29, 2022, 7:00AM
Globe Newswire - Sep 22, 2022, 7:00AM
Globe Newswire - Sep 8, 2022, 9:15AM
Globe Newswire - Sep 6, 2022, 7:00AM
Globe Newswire - Aug 31, 2022, 7:00AM
Globe Newswire - Aug 10, 2022, 7:00AM
Globe Newswire - Aug 3, 2022, 7:00AM
Globe Newswire - Jul 21, 2022, 7:00AM
Globe Newswire - Jul 7, 2022, 7:00AM
Globe Newswire - Jun 21, 2022, 8:05PM
PRNewswire - Jun 16, 2022, 8:50AM
Globe Newswire - Jun 1, 2022, 7:00AM
Globe Newswire - May 24, 2022, 7:00AM
Globe Newswire - May 17, 2022, 7:00AM
Globe Newswire - May 16, 2022, 7:00AM
Globe Newswire - May 11, 2022, 1:30PM
Globe Newswire - May 9, 2022, 4:57PM
Globe Newswire - May 2, 2022, 7:00AM
Globe Newswire - Apr 21, 2022, 7:00AM
Globe Newswire - Apr 5, 2022, 7:00AM
Globe Newswire - Mar 22, 2022, 7:00AM
Globe Newswire - Mar 1, 2022, 6:00AM
Globe Newswire - Feb 28, 2022, 4:05PM
Globe Newswire - Feb 28, 2022, 7:00AM
Globe Newswire - Feb 15, 2022, 7:00AM
Globe Newswire - Feb 10, 2022, 7:00AM
Globe Newswire - Jan 6, 2022, 7:00AM
InvestorsObserver - 23 hours ago
InvestorsObserver - 2 days ago
InvestorsObserver - Nov 17, 2022, 1:49PM
Seeking Alpha - Nov 15, 2022, 8:06AM
TipRanks - Nov 15, 2022, 7:05AM
Seeking Alpha - Nov 14, 2022, 8:39AM
TalkMarkets - Nov 11, 2022, 9:31PM
TalkMarkets - Nov 7, 2022, 4:47PM
InvestorsObserver - Nov 3, 2022, 3:36PM
Seeking Alpha - Nov 2, 2022, 9:29AM
TalkMarkets - Oct 27, 2022, 7:09PM
TalkMarkets - Oct 24, 2022, 10:00AM
InvestorsObserver - Oct 12, 2022, 3:11PM
InvestorsObserver - Oct 10, 2022, 3:41PM
InvestorsObserver - Oct 6, 2022, 3:08PM
Seeking Alpha - Oct 6, 2022, 7:27AM
TalkMarkets - Oct 2, 2022, 12:02AM
InvestorsObserver - Sep 30, 2022, 2:59PM
TalkMarkets - Sep 25, 2022, 11:07PM
InvestorsObserver - Sep 20, 2022, 3:22PM
InvestorsObserver - Sep 19, 2022, 3:41PM
TalkMarkets - Sep 18, 2022, 11:45AM
TalkMarkets - Sep 10, 2022, 6:50PM
InvestorsObserver - Sep 8, 2022, 3:19PM
TalkMarkets - Sep 3, 2022, 5:16PM
TalkMarkets - Aug 28, 2022, 5:58PM
TalkMarkets - Aug 26, 2022, 6:02PM
InvestorsObserver - Aug 26, 2022, 2:56PM
InvestorsObserver - Aug 23, 2022, 12:42PM
Sector: Health Care.Industry: Pharmaceuticals
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.220-0.200 0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Zynerba Pharmaceuticals (ZYNE) stock?

A

You can purchase shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zynerba Pharmaceuticals's (ZYNE) competitors?

Q

What is the target price for Zynerba Pharmaceuticals (ZYNE) stock?

A

The latest price target for Zynerba Pharmaceuticals (NASDAQ: ZYNE) was reported by Canaccord Genuity on Thursday, June 23, 2022. The analyst firm set a price target for 11.00 expecting ZYNE to rise to within 12 months (a possible 1745.64% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zynerba Pharmaceuticals (ZYNE)?

A

The stock price for Zynerba Pharmaceuticals (NASDAQ: ZYNE) is $0.596 last updated December 2, 2022, 9:00 PM UTC.

Q

Does Zynerba Pharmaceuticals (ZYNE) pay a dividend?

A

There are no upcoming dividends for Zynerba Pharmaceuticals.

Q

When is Zynerba Pharmaceuticals (NASDAQ:ZYNE) reporting earnings?

A

Zynerba Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Zynerba Pharmaceuticals (ZYNE) going to split?

A

There is no upcoming split for Zynerba Pharmaceuticals.

Q

What sector and industry does Zynerba Pharmaceuticals (ZYNE) operate in?

A

Zynerba Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.